PDCD1 and acute myeloid leukemia: Given the results showing the effect of BETi on T cells from the AML mice in vitro, we sought to determine the in vivo therapeutic efficacy of BETi in combination with anti-PD1 and whether they also modulate the tumor immune microenvironment.